Thiomers in noninvasive polypeptide delivery: In vitro and in vivo characterization of a polycarbophil-cysteine/glutathione gel formulation for human growth hormone

Journal of Pharmaceutical Sciences

Volumn 93, Issue 7, 2004, Pages 1682-1691

  Leitner, Verena M ^a   Guggi, Davide ^a   Bernkop Schnürch, Andreas ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Glutathione; Human growth hormone (hGH); Noninvasive delivery system; Thiolated polymers

Indexed keywords

DEXTRAN; FLUORESCENT DYE; HUMAN GROWTH HORMONE; MONOMER; NOVEON; PENETRATION ENHANCING AGENT; POLYCARBOPHIL; POLYCARBOPHIL CYSTEINE; POLYCARBOPHIL GLUTATHIONE; THIOMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CATTLE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; GEL; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR WEIGHT; NON INVASIVE DRUG DELIVERY; NONHUMAN; NOSE MUCOSA; RAT;

EID: 3042684176     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.20069     Document Type: Article

References (33)

1. Ugwoke MI, Verbeke N, Kinget R. 2001. The biopharmaceutical aspects of nasal mucoadhesive drug delivery. J Pharm Pharmacol 53:3-21.
2. Lang S, Rothen-Rutishauser B, Perriard J-C, Schmidt MC, Merkle HP. 1998. Permeation and pathways of human calcitonin (hCT) across excised bovine nasal mucosa. Peptides 19:599-607.
3. Yamamoto A, Iseki T, Ochi-Sugiyama M, Okada N, Fujita T, Muranishi S. 2001. Absorption of water-soluble compounds with different molecular weights and [Asul.7]-eel calcitonin from various mucosal administration sites. J Control Release 76:363-374.
4. Illum L, Fisher AN, Jabbal-Gill I, Davis SS. 2001. Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm 222:109-119.
5. Callens C, Pringels E, Remon JP. 2003. Influence of multiple nasal administrations of bioadhesive powders on the insulin bioavailability. Int J Pharm 250:415-422.
6. Law SL, Huang KJ, Chou HY. 2001. Preparation of desmopressin-containing liposomes for intranasal delivery. J Control Release 70:375-382.
7. Abe K, Irie T, Adachi H, Uekama K. 1995. Combined use of 2-hydroxypropyl-cyclodextrin and a lipophilic absorption enhancer in nasal delivery of the LHRH agonist, buserelin acetate, in rats. Int J Pharm 123:103-112.
8. Oechslein CR, Fricker G, Kissel T. 1996. Nasal delivery of octreotide: Absorption enhancement by particulate carrier systems. Int J Pharm 139:25-32.
9. Illum L. 2003. Nasal drug delivery: Possibilities, problems and solutions. J Control Release 87:187-198.
10. Sarkar MA. 1992. Drug metabolism in the nasal mucosa. Pharm Res 9:1-9.
11. Clausen AE, Bernkop-Schnürch A. 2000. In vitro evaluation of the permeation-enhancing effect of thiolated polycarbophil. J Pharm Sci 89:1253-1261.
12. Bernkop-Schnürch A, Steininger S. 2000. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm 194:239-247.
13. Bernkop-Schnürch A, Zarti H, Walker GF. 2001. Thiolation of polycarbophil enhances its inhibition of soluble and intestinal brush border membrane bound aminopeptidase N. J Pharm Sci 90:1907-1914.
14. Clausen AE, Kast CE, Bernkop-Schnürch A. 2002. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 19:602-608.
15. Guggi D, Krauland AH, Bernkop-Schnürch A. 2003. Systemic peptide delivery via the stomach: In vivo evaluation of an oral dosage form for salmon calcitonin. J Control Release 92:125-135.
16. Kast CE, Guggi D, Langoth N, Bernkop-Schnürch A. 2002. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm Res 20:931-936.
17. Bernkop-Schnürch A, Schwarz V, Steininger S. 1999. Polymers with thiol groups: A new generation of mucoadhesive polymers? Pharm Res 16:876-881.
18. Hornof M, Weyenberg W, Ludwig A, Bernkop-Schnürch A. 2003. Mucoadhesive ocular insert based on thiolated poly(acrylic acid): Development and in vivo evaluation in humans. J Control Release 89:419-428.
19. Bechtold S, Ripperger P, Muhlbayer D, Truckenbrodt H, Hafner R, Butenandt O, Schwarz HP. 2001. GH therapy in juvenile chronic arthritis: Results of a two-year controlled study on growth and bone. J Clin Endocrinol Metab 86:5737-5744.
20. Venn RM, Bryant A, Hall GM, Grounds RM. 2001. Effects of dexmedetomidine on adrenocortical function, and the cardiovascular, endocrine and inflammatory responses in post-operative patients needing sedation in the intensive care unit. Br J Anaesth 86:650-656.
21. Higuchi T. 1960. Physical chemical analysis of percutaneous absorption process from creams and ointments. J Soc Cosmet Chem 11:85-97.
22. Baldwin PA, Klingbeil CK, Grimm CJ, Longenecker JP. 1990. The effect of sodium tauro-24,25-dihydrofusidate on the nasal absorption of human growth hormone in three animal models. Pharm Res 7:547-552.
23. Agerholm C, Bastholm L, Johansen PB, Nielsen MH, Elling F. 1994. Epithelial transport and bioavailability of intranasally administered human growth hormone formulated with the absorption enhancers didecanoyl-L-alpha- phosphatidylcholine and alpha-cyclodextrin in rabbits. J Pharm Sci 83:1706-1711.
24. Riley RG, Green KL, Smart JD, Tsibouklis J, Davis JA, Hampson F, Dettmar PW, Wilber WR. 2001. The gastrointestinal transit profile of 14C-labelled poly(acrylic acids): An in vivo study. Biomaterials 22:1861-1867.
25. Osth K, Paulsson M, Bjork E, Edsman K. 2002. Evaluation of drug release from gels on pig nasal mucosa in a horizontal Ussing chamber. J Control Release 83:377-388.
26. Clausen AE, Bernkop-Schnürch A. 2001. In vitro evaluation of matrix tablets based on thiolated polycarbophil. Pharm Ind 63:312-317.
27. Marschütz MK, Bernkop-Schnürch A. 2002. Thiolated polymers: Self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci 15:387-394.
28. Leitner VM, Walker GF, Bernkop-Schnürch A. 2003. Thiolated polymers: Evidence for the formation of disulphide bonds with mucus glycoproteins. Eur J Pharm Biopharm 56:207-214.
29. Tannenbaum GS, Choi HK, Gurd W, Waxman DJ. 2001. Temporal relationship between the sexually dimorphic spontaneous GH secretory profiles and hepatic STAT5 activity. Endocrinology 142:4599-4606.
30. Kagatani S, Inaba N, Fukui M, Sonobe T. 1998. Nasal absorption kinetics of human growth hormone enhanced by acylcarnitines in rats. Int J Pharm 169:245-253.
31. Mayor S, Illum L. 1994. An investigation of the effect of anaesthetics on the nasal absorption of insulin in rats. Proc Int Symp Control Release Bioact Mater 21:334-335.
32. O'Hagan DT, Critchley H, Farraj NF, Fisher AN, Johansen BR, Davis SS, Illum L. 1990. Nasal absorption enhancers for biosynthetic human growth hormone in rats. Pharm Res 7:772-776.
33. Illum L. 1996. Nasal delivery. The use of animal models to predict performance in man. J Drug Target 3:427-442.